04 July 2025
: Case report 
Navigating Diagnostic Ambiguities in Cardiac Amyloidosis: Insights from a Case with Delayed Diagnosis of AL Amyloidosis
Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Unexpected drug reaction, Educational Purpose (only if useful for a systematic review or synthesis)
Antonio Al Hazzouri ADEF 1, Rose-Mary Daou
ADEF 1, Philippe Attieh ADEF 1, Zahi Ibrahim ADEF 1, Hilda E. Ghadieh EG 1, Bernard Harbieh ADEF 1*
DOI: 10.12659/AJCR.948092
Am J Case Rep 2025; 26:e948092
Figure 8 Algorithms that summarize the approach used in treatment of cardiac amyloidosis. Transthyretin amyloidosis (ATTR); Heart failure (HF); Direct oral anticoagulant (DOAC); Cardiac variant transthyretin amyloidosis ATTRwt-CM; Variant transthyretin amyloidosis (ATTRv); Permanent pacemaker (PPM); Implantable cardioverter-defibrillator (ICD); Cardiac resynchronization therapy (CRT); Ventricular tachycardia (VT); Sudden cardiac death (SCD).